Free Trial
TSE:NVCN

Neovasc (NVCN) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
C$40.15
C$40.15
52-Week Range
N/A
Volume
399 shs
Average Volume
2,123 shs
Market Capitalization
C$110.81 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NVCN stock logo

About Neovasc Stock (TSE:NVCN)

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

NVCN Stock News Headlines

Neovasc (TSE:NVCN) Stock Price Up 0.6%
Aptose Biosciences Inc (APS)
Closing Bell: Neovasc Inc up on Thursday (NVCN)
Shockwave Medical to Acquire Neovasc
Shockwave Medical to Buy Neovasc for $75 Million
Neovasc Inc. (NVCN) Q3 2022 Earnings Call Transcript
Neovasc Reducer Obtains U.S. Outpatient Reimbursement
Neovasc Inc. (NVCN)
Stocks in play: Neovasc Inc
Neovasc Q1 Earnings Preview
See More Headlines
Receive NVCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry
Surgical & Medical Instrument Manufacturing
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
49
Year Founded
N/A

Profitability

Net Income
C$-33,520,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$3.11 million
Book Value
C$10.22 per share

Miscellaneous

Free Float
N/A
Market Cap
C$110.81 million
Optionable
Not Optionable
Beta
2.01
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Fredericus A. Colen (Age 71)
    Pres, CEO & Director
    Comp: $2.59M
  • Mr. Christopher Clark B.A. (Age 51)
    BA (Honours), C.A., CA, PgD, CFO & Corp. Sec.
    Comp: $1.42M
  • Mr. William Reed Little (Age 52)
    Chief Operating Officer
    Comp: $1.2M
  • Mr. John Christopher Panton (Age 56)
    Chief Quality Officer
    Comp: $505.88k
  • Sarah Marie-Hodgson Gallagher
    VP of Clinical Affairs

NVCN Stock Analysis - Frequently Asked Questions

How do I buy shares of Neovasc?

Shares of NVCN stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:NVCN) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners